Circulating Tumor Cells Market to Witness Considerable Growth till 2024A Chapter by David JonesCirculating Tumor Cells Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 | Hexa ResearchThe global circulating tumor
cells market is primarily fueled by high incidence of cancer and other
lifestyle diseases, growing global population, and technological developments.
CTCs are cancer cells that start drifting away from metastatic or primary tumor
sites and start circulating in the bloodstream. These are primarily utilized in
molecular analysis, such as liquid biopsies. Rising adoption of companion
diagnostic options & personalized medicine for total eradication of onsite
cancer could create lucrative opportunities for further market progress.
The global industry is at present
characterized by translational research and genomics. These systems lead to
better detection, analysis, and enumeration of circulating tumor cells present
in patients. The need for oncology diagnosis, screening, and therapy propels
the overall industry. However, complexities in the isolation of tumor cells can
impede market growth during the forecast period (2016 to 2024).
Browse
Details of Report @ - https://www.hexaresearch.com/research-report/circulating-tumor-cells-industry
The worldwide industry is segmented on the basis of technologies, applications, and regions. Based on technologies, the categories are tumor cell detection & enrichment, centrifugation, molecular, immunomagnetic, optical, filtration, and immunological. Tumor cell enrichment & detection dominated the market in 2013. High degree of accuracy, faster outcomes, and easy sample collection are factors that fuel this segment. It may grow at a whopping CAGR of 27% from 2016 to 2024. Also, immunomagnetic & immunological technologies may gain popularity during this period. This owes to their compatibility with all genome sequencing and the capacity to facilitate effective analysis with smaller blood samples.
The areas of application are colorectal cancer,
prostate cancer, and breast cancer. The industry was led by the breast cancer
segment in 2013. Rising incidence of breast cancer attributes to high frequency
of malignancy and the growth of circulatory tumor cells from small sized
primary tumors. What makes cancer a terminal disease is the spreading of cancer
cells to the healthier organs & body cells; a phenomenon known as
metastasis.
Geographically, the industry is categorized into North
America, Europe, Asia Pacific, and Rest of the World. North America is a strong
regional market that is driven by favorable government initiatives, exhaustive
R&D activities, and updated technology infrastructure. Growing patient
awareness too plays a vital role in positively influencing this regional
market. It is expected that Asia Pacific economies, such as China and India will
witness considerable growth during the forecast period. The region is propelled
by growing awareness about hospital acquired infections and surging healthcare
expenditure.
Prominent companies operating in the worldwide
Circulating Tumor Cells Market are AVIVA BioSciences Corporation; Advanced Cell
Diagnostics Inc.; Silicon Biosystems, Vitatex Inc.; and Veridex LLC. Clinicians
& researchers for a long time have tried developing effective methods for
cancer screening & its progression. Commonly used methods involve blood
tests for screening biomarkers. For example, PSA (prostate-specific antigen)
levels are indicators of prostate cancer. Other frequently employed screening
methods are MRI (magnetic resonance imaging) or computed tomography. However,
one particular approach that holds good promise is the analysis of CTCs
(circulating tumor cells). Scientists point out that the genetic analysis of
CTCs could throw light on patients’ suitability for targeted cancer therapies.
This could help determine the mutational landscape of tumors as well.
Browse Related Category Market
Reports @ https://www.hexaresearch.com/research-category/biotechnology-industry
About Us: Hexa
Research is a market research and consulting organization, offering industry
reports, custom research and consulting services to a host of key industries
across the globe. We offer comprehensive business intelligence in the form of
industry reports which help our clients obtain clarity about their business
environment and enable them to undertake strategic growth initiatives. © 2017 David Jones |
Stats
79 Views
Added on August 24, 2017 Last Updated on August 24, 2017 Tags: Circulating Tumor Cells Market AuthorDavid Jonescalifornia, CAAboutResearch Analyst At Hexa Research Which Provides Research Content For All Types Of Domains do check my Articles more..Writing
|